Asylia Therapeutics, Inc. Announces Closing of $14.5 Million Series A Financing

NEXT STORY
Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore
PREV STORY
Inovalon Receives Key Patent Award for On-Demand Real-Time Patient-Specific Data Aggregation and Analysis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G1 Therapeutics to Present at Investor Conferences in March 2018

RESEARCH TRIANGLE PARK, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

author_avatar
NASDAQ Market News

Stemline Therapeutics Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for SL-401

NEW YORK, Aug. 23, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today ...

author_avatar
NASDAQ Market News

GeoVax to Present at the 2018 ASM Microbe Conference

ATLANTA, GA. , May 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), ...

author_avatar
NASDAQ Market News